168 related articles for article (PubMed ID: 36203602)
1. Increased sIL-2Rα leads to obstruction of IL-2 biological function and Treg cells differentiation in SLE patients
Long D; Yu S; Zhang L; Guo Y; Xu S; Rao Y; Huang Z; Luo Q; Li J
Front Immunol; 2022; 13():938556. PubMed ID: 36203602
[TBL] [Abstract][Full Text] [Related]
2. [Serum interleukin-2 receptor
Tian JY; Zhang X; Cheng G; Liu QH; Wang SY; He J
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 53(6):1083-1087. PubMed ID: 34916686
[TBL] [Abstract][Full Text] [Related]
3. Soluble IL-2Rα facilitates IL-2-mediated immune responses and predicts reduced survival in follicular B-cell non-Hodgkin lymphoma.
Yang ZZ; Grote DM; Ziesmer SC; Manske MK; Witzig TE; Novak AJ; Ansell SM
Blood; 2011 Sep; 118(10):2809-20. PubMed ID: 21719603
[TBL] [Abstract][Full Text] [Related]
4. Soluble IL-2Rα correlates with imbalances of Th1/Th2 and Tc1/Tc2 cells in patients with acute brucellosis.
Sun HL; Ma CJ; Du XF; Yang SY; Lv X; Zhao H; Wang LH; Tang YX; Li XW; Jiang RM
Infect Dis Poverty; 2020 Jul; 9(1):92. PubMed ID: 32660627
[TBL] [Abstract][Full Text] [Related]
5. The soluble IL-2 receptor α/CD25 as a modulator of IL-2 function.
Lokau J; Petasch LM; Garbers C
Immunology; 2024 Mar; 171(3):377-387. PubMed ID: 38037265
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cells upregulate Treg cells via sHLA-G in SLE patients.
Chen C; Liang J; Yao G; Chen H; Shi B; Zhang Z; Zhao C; Zhang H; Sun L
Int Immunopharmacol; 2017 Mar; 44():234-241. PubMed ID: 28129605
[TBL] [Abstract][Full Text] [Related]
7. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus.
Cai Z; Wong CK; Kam NW; Dong J; Jiao D; Chu M; Lam CW; Tam LS
Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926
[TBL] [Abstract][Full Text] [Related]
8. Inhibiting IL-2 signaling and the regulatory T-cell pathway using computationally designed peptides.
Price-Troska T; Yang ZZ; Diller D; Bayden A; Jarosinski M; Audie J; Ansell SM
Invest New Drugs; 2019 Feb; 37(1):9-16. PubMed ID: 29696509
[TBL] [Abstract][Full Text] [Related]
9. Use of an antibody against the soluble interleukin 2 receptor alpha subunit can modulate the stability and biodistribution of interleukin-2.
Kobayashi H; Tagaya Y; Han ES; Kim IS; Le N; Paik CH; Pastan I; Nelson DL; Waldmann TA; Carrasquillo JA
Cytokine; 1999 Dec; 11(12):1065-75. PubMed ID: 10623432
[TBL] [Abstract][Full Text] [Related]
10. CD(+)(4)CD(+)(25) Treg cells in thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus patients.
Huang H; Sun W; Liang Y; Long XD; Peng Y; Liu Z; Wen X; Jia M
Ren Fail; 2014 Sep; 36(8):1263-7. PubMed ID: 24990576
[TBL] [Abstract][Full Text] [Related]
11. Low expressions of PD-L1 and CTLA-4 by induced CD4
Zhao L; Zhou X; Zhou X; Wang H; Gu L; Ke Y; Zhang M; Ji X; Yang X
Cytokine; 2020 Sep; 133():155119. PubMed ID: 32535334
[TBL] [Abstract][Full Text] [Related]
12. Increased serum-soluble interleukin-2 receptor in burn patients: characterization and effects on the immune system.
Jobin N; Garrel D; Bernier J
Hum Immunol; 2000 Mar; 61(3):233-46. PubMed ID: 10689113
[TBL] [Abstract][Full Text] [Related]
13. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells.
Yan B; Ye S; Chen G; Kuang M; Shen N; Chen S
Arthritis Rheum; 2008 Mar; 58(3):801-12. PubMed ID: 18311820
[TBL] [Abstract][Full Text] [Related]
14. Altered frequency of Th17 and Treg cells in new-onset systemic lupus erythematosus patients.
Chen M; Chen X; Wan Q
Eur J Clin Invest; 2018 Nov; 48(11):e13012. PubMed ID: 30079446
[TBL] [Abstract][Full Text] [Related]
15. The metalloprotease ADAM10 generates soluble interleukin-2 receptor alpha (sCD25) in vivo.
Kirschke S; Ogunsulire I; Selvakumar B; Schumacher N; Sezin T; Rose-John S; Scheffold A; Garbers C; Lokau J
J Biol Chem; 2022 Jun; 298(6):101910. PubMed ID: 35398356
[TBL] [Abstract][Full Text] [Related]
16. Soluble interleukin-2 receptor α and interleukin-2 serum levels in patients with basal cell carcinoma.
Sobjanek M; Bien E; Zablotna M; Sokolowska-Wojdylo M; Sikorska M; Lange M; Nowicki R
Postepy Dermatol Alergol; 2016 Aug; 33(4):263-8. PubMed ID: 27605896
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of plasma IL-2 and sIL-2Rα in patients with first-ever ischaemic stroke.
Zhao H; Li F; Huang Y; Zhang S; Li L; Yang Z; Wang R; Tao Z; Han Z; Fan J; Zheng Y; Ma Q; Luo Y
J Neuroinflammation; 2020 Aug; 17(1):237. PubMed ID: 32795376
[TBL] [Abstract][Full Text] [Related]
18. The fractional excretion of soluble interleukin-2 receptor-alpha is an excellent predictor of the interleukin-2 receptor-alpha status after treatment with daclizumab.
ter Meulen CG; Jacobs CW; Wetzels JF; Klasen IS; Hilbrands LB; Hoitsma AJ
Transplantation; 2004 Jan; 77(2):281-6. PubMed ID: 14742994
[TBL] [Abstract][Full Text] [Related]
19. Soluble interleukin-2 receptor α activation in a Children's Oncology Group randomized trial of interleukin-2 therapy for pediatric acute myeloid leukemia.
Lange BJ; Yang RK; Gan J; Hank JA; Sievers EL; Alonzo TA; Gerbing RB; Sondel PM
Pediatr Blood Cancer; 2011 Sep; 57(3):398-405. PubMed ID: 21681921
[TBL] [Abstract][Full Text] [Related]
20. The changes of Treg and Th17 cells relate to serum 25(OH)D in patients with initial-onset childhood systemic lupus erythematosus.
Jiang LJ; Rong ZH; Zhang HF
Front Pediatr; 2023; 11():1228112. PubMed ID: 37681199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
